Viewing Study NCT00748657


Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2026-04-26 @ 4:55 PM
Study NCT ID: NCT00748657
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2008-09-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Ovarian Epithelial Tumor View
None Ovarian Granulosa Cell Tumor View
None Ovarian Gynandroblastoma View
None Ovarian Sertoli-Leydig Cell Tumor View
None Ovarian Sex Cord Tumor With Annular Tubules View
None Ovarian Sex Cord-Stromal Tumor View
None Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types View
None Ovarian Steroid Cell Tumor View
Keywords: